Psychopharmacology

, Volume 184, Issue 3–4, pp 409–416 | Cite as

Effects of a nicotine conjugate vaccine on the acquisition and maintenance of nicotine self-administration in rats

  • Mark G. LeSage
  • Daniel E. Keyler
  • Yoko Hieda
  • Greg Collins
  • Danielle Burroughs
  • Chap Le
  • Paul R. Pentel
Original Investigation

Abstract

Rationale

Immunization of rats against nicotine using a nicotine conjugate vaccine reduces the distribution of nicotine to brain in rats and attenuates some of nicotine's physiological and behavioral effects. It is not known whether such a vaccine can attenuate nicotine's reinforcing effects.

Objective

The present experiment was conducted to determine whether a nicotine conjugate vaccine could interfere with the acquisition and maintenance of nicotine self-administration (NSA) in rats given 23 h day−1 access to nicotine.

Methods

To examine acquisition of NSA, rats were vaccinated with nicotine or control immunogen prior to being given access to a 0.01 mg kg−1 infusion−1 nicotine under a fixed-ratio(FR) 1 schedule for week 1, FR 2 for week 2, and FR 3 for week 3. Acquisition of cocaine self-administration (CSA) was similarly examined to determine the specificity of vaccination effects. To examine maintenance of NSA, rats were initially trained to self-administer nicotine under an FR 3 schedule, and then vaccinated with nicotine or control immunogen while NSA continued to be monitored.

Results

NSA was significantly lower in vaccinated rats compared to controls during the acquisition protocol, with a 38% decrease in the number of infusions during the last week of training. The percentage of rats meeting acquisition criteria in the vaccinated group was lower (36%) than that in the control group (70%), but this difference was not statistically significant. Vaccination did not affect acquisition of CSA, demonstrating its specificity for nicotine. Maintenance of NSA was significantly reduced in vaccinated rats as compared to controls after the final vaccine injection, with a mean reduction of 57%. There was no evidence in either protocol that vaccinated rats attempted to compensate for altered nicotine distribution by increasing nicotine intake.

Conclusion

These data suggest that vaccination against nicotine can reduce the reinforcing effects of nicotine in rats and may have therapeutic potential for the treatment of tobacco dependence.

Keywords

Nicotine Cocaine Self-administration Rats Vaccination Active immunization Nicotine-specific antibody 

Notes

Acknowledgements

The authors thank Cathy Ross, Heather Wendorf, Matthew Dufek, Thomas Bramwell, Sarah Polcher, and Erriane Gustaf for their technical assistance during the conduct of the study. The authors also thank Dr. Marilyn Carroll for her advice on the cocaine self-administration protocol. Yoko Heida is now at Shimane University School of Medicine, Izumo City, Japan. Greg Collins is now at the University of Michigan Medical School, Ann Arbor, MI. This research was supported by NIDA grants R01-DA10714 and U19-DA13327 and the Minneapolis Medical Research Foundation.

References

  1. Baird TJ, Deng SX, Landry DW, Winger G, Woods JH (2000) Natural and artificial enzymes against cocaine. I. Monoclonal antibody 15A10 and the reinforcing effects of cocaine in rats. J Pharmacol Exp Ther 295:1127–1134PubMedGoogle Scholar
  2. Belluzzi JD, Wang R, Leslie FM (2005) Acetaldehyde enhances acquisition of nicotine self-administration in adolescent rats. Neuropsychopharmacology 30:705–712CrossRefPubMedGoogle Scholar
  3. Benowitz NL, Perez-Stable EJ, Herrera B, Jacob P III (2002) Slower metabolism and reduced intake of nicotine from cigarette smoking in Chinese–Americans. J Natl Cancer Inst 94:108–115PubMedGoogle Scholar
  4. Bonese KF, Wainer BH, Fitch FW, Rothberg RM, Schuster CR (1974) Changes in heroin self-administration by a rhesus monkey after morphine immunisation. Nature 252:708–710CrossRefPubMedGoogle Scholar
  5. Bozarth MA, Wise RA (1985) Toxicity associated with long-term intravenous heroin and cocaine self-administration in the rat. JAMA 254:81–83CrossRefPubMedGoogle Scholar
  6. Caggiula AR, Donny EC, White AR, Chaudhri N, Booth S, Gharib MA, Hoffman A, Perkins KA, Sved AF (2001) Cue dependency of nicotine self-administration and smoking. Pharmacol Biochem Behav 70:515–530CrossRefPubMedGoogle Scholar
  7. Carrera MR, Ashley JA, Zhou B, Wirsching P, Koob GF, Janda KD (2000) Cocaine vaccines: antibody protection against relapse in a rat model. Proc Natl Acad Sci U S A 97:6202–6206CrossRefPubMedGoogle Scholar
  8. Carroll ME, Lac ST, Nygaard SL (1989) A concurrently available nondrug reinforcer prevents the acquisition or decreases the maintenance of cocaine-reinforced behavior. Psychopharmacology (Berl) 97:23–29CrossRefGoogle Scholar
  9. Cerny EH, Levy R, Mauel J, Mpandi M, Mutter M, Henzelin-Nkubana C, Patiny L, Tuchscherer G, Cerny T (2002) Preclinical development of a vaccine ‘against smoking’. Onkologie 25:406–411CrossRefPubMedGoogle Scholar
  10. Corrigall WA (1999) Nicotine self-administration in animals as a dependence model. Nicotine Tob Res 1:11–20CrossRefPubMedGoogle Scholar
  11. Griffiths RR, Bigelow GE, Henningfield JE (1980) Similarities in animal and human drug-taking behavior. In: Mello NK (ed) Advances in substance abuse. JAI Press, Greenwich, CT, pp 1–90Google Scholar
  12. Hall W (2002) The prospects for immunotherapy in smoking cessation. Lancet 360:1089–1091CrossRefPubMedGoogle Scholar
  13. Haney M, Kosten TR (2004) Therapeutic vaccines for substance dependence. Expert Rev Vaccines 3:11–18CrossRefPubMedGoogle Scholar
  14. Hieda Y, Keyler DE, VanDeVoort JT, Niedbala RS, Raphael DE, Ross CA, Pentel PR (1999) Immunization of rats reduces nicotine distribution to brain. Psychopharmacology (Berl) 143:150–157CrossRefGoogle Scholar
  15. Hieda Y, Keyler DE, Ennifar S, Fattom A, Pentel PR (2000) Vaccination against nicotine during continued nicotine administration in rats: immunogenicity of the vaccine and effects on nicotine distribution to brain. Int J Immunopharmacol 22:809–819CrossRefPubMedGoogle Scholar
  16. Horger BA, Shelton K, Schenk S (1990) Preexposure sensitizes rats to the rewarding effects of cocaine. Pharmacol Biochem Behav 37:707–711CrossRefPubMedGoogle Scholar
  17. Horger BA, Wellman PJ, Morien A, Davies BT, Schenk S (1991) Caffeine exposure sensitizes rats to the reinforcing effects of cocaine. Neuroreport 2:53–56PubMedCrossRefGoogle Scholar
  18. Jacob P, Wilson M, Benowitz NL (1981) Improved gas chromatographic method for the determination of nicotine and cotinine in biologic fluids. J Chromatogr 222:61–70PubMedCrossRefGoogle Scholar
  19. Kantak KM, Collins SL, Lipman EG, Bond J, Giovanoni K, Fox BS (2000) Evaluation of anti-cocaine antibodies and a cocaine vaccine in a rat self-administration model. Psychopharmacology (Berl) 148:251–262CrossRefGoogle Scholar
  20. Kantak KM, Collins SL, Bond J, Fox BS (2001) Time course of changes in cocaine self-administration behavior in rats during immunization with the cocaine vaccine IPC-1010. Psychopharmacology (Berl) 153:334–340CrossRefGoogle Scholar
  21. Keyler DE, Hieda Y, St Peter J, Pentel PR (1999) Altered disposition of repeated nicotine doses in rats immunized against nicotine. Nicotine Tob Res 1:241–249CrossRefPubMedGoogle Scholar
  22. Killian A, Bonese K, Rothberg RM, Wainer BH, Schuster CR (1978) Effects of passive immunization against morphine on heroin self-administration. Pharmacol Biochem Behav 9:347–352CrossRefPubMedGoogle Scholar
  23. LeSage MG, Keyler DE, Shoeman D, Raphael D, Collins G, Pentel PR (2002) Continuous nicotine infusion reduces nicotine self-administration in rats with 23-h/day access to nicotine. Pharmacol Biochem Behav 72:279–289CrossRefPubMedGoogle Scholar
  24. LeSage MG, Keyler DE, Collins G, Pentel PR (2003) Effects of continuous nicotine infusion on nicotine self-administration in rats: relationship between continuously infused and self-administered nicotine doses and serum concentrations. Psychopharmacology (Berl) 170(3):278–286CrossRefGoogle Scholar
  25. LeSage MG, Burroughs D, Dufek M, Keyler DE, Pentel PR (2004) Reinstatement of nicotine self-administration in rats by presentation of nicotine-paired stimuli, but not nicotine priming. Pharmacol Biochem Behav 79:507–513CrossRefPubMedGoogle Scholar
  26. Lindblom N, de Villiers SH, Kalayanov G, Gordon S, Johansson AM, Svensson TH (2002) Active immunization against nicotine prevents reinstatement of nicotine-seeking behavior in rats. Respiration 69:254–260CrossRefPubMedGoogle Scholar
  27. Malin DH (2002) Passive immunization against nicotine attenuates dependence as measured by mecamylamine-precipitated withdrawal. Soc Res Nicotine Tob Proc 8:RP1Google Scholar
  28. Malin DH, Lake JR, Lin A, Saldana M, Balch L, Irvin ML, Chandrasekara H, Alvarado CL, Hieda Y, Keyler DE, Pentel PR, Ennifar S, Basham LE, Naso R, Fattom A (2001) Passive immunization against nicotine prevents nicotine alleviation of nicotine abstinence syndrome. Pharmacol Biochem Behav 68:87–92CrossRefPubMedGoogle Scholar
  29. Malin DH, Alvarado CL, Woodhouse KS, Karp H, Urdiales E, Lay D, Appleby P, Moon WD, Ennifar S, Basham L, Fattom A (2002) Passive immunization against nicotine attenuates nicotine discrimination. Life Sci 70:2793–2798CrossRefPubMedGoogle Scholar
  30. McMillan DE, Hardwick WC, Li M, Gunnell MG, Carroll FI, Abraham P, Owens SM (2004) Effects of murine-derived anti-methamphetamine monoclonal antibodies on (+)-methamphetamine self-administration in the rat. J Pharmacol Exp Ther 309:1248–1255CrossRefPubMedGoogle Scholar
  31. Meijler MM, Matsushita M, Altobell LJ III, Wirsching P, Janda KD (2003) A new strategy for improved nicotine vaccines using conformationally constrained haptens. J Am Chem Soc 125:7164–7165CrossRefPubMedGoogle Scholar
  32. Pentel P, Malin D (2002) A vaccine for nicotine dependence: targeting the drug rather than the brain. Respiration 69:193–197CrossRefPubMedGoogle Scholar
  33. Pentel PR, Malin DH, Ennifar S, Hieda Y, Keyler DE, Lake JR, Milstein JR, Basham LE, Coy RT, Moon JW, Naso R, Fattom A (2000) A nicotine conjugate vaccine reduces nicotine distribution to brain and attenuates its behavioral and cardiovascular effects in rats. Pharmacol Biochem Behav 65:191–198CrossRefPubMedGoogle Scholar
  34. Rose JE, Corrigall WA (1997) Nicotine self-administration in animals and humans: similarities and differences. Psychopharmacology (Berl) 130:28–40CrossRefGoogle Scholar
  35. Sanderson SD, Cheruku SR, Padmanilayam MP, Vennerstrom JL, Thiele GM, Palmatier MI, Bevins RA (2003) Immunization to nicotine with a peptide-based vaccine composed of a conformationally biased agonist of C5a as a molecular adjuvant. Int Immunopharmacol 3:137–146CrossRefPubMedGoogle Scholar
  36. Sellers EM, Kaplan HL, Tyndale RF (2000) Inhibition of cytochrome P450 2A6 increases nicotine's oral bioavailability and decreases smoking. Clin Pharmacol Ther 68:35–43CrossRefPubMedGoogle Scholar
  37. Shoaib M, Stolerman IP (1999) Plasma nicotine and cotinine levels following intravenous nicotine self- administration in rats. Psychopharmacology (Berl) 143:318–321CrossRefGoogle Scholar
  38. Valentine JD, Hokanson JS, Matta SG, Sharp BM (1997) Self-administration in rats allowed unlimited access to nicotine. Psychopharmacology (Berl) 133:300–304CrossRefGoogle Scholar
  39. Vocci FJ, Chiang CN (2001) Vaccines against nicotine: how effective are they likely to be in preventing smoking? CNS Drugs 15:505–514CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2005

Authors and Affiliations

  • Mark G. LeSage
    • 1
    • 2
  • Daniel E. Keyler
    • 1
  • Yoko Hieda
    • 2
  • Greg Collins
    • 2
  • Danielle Burroughs
    • 2
  • Chap Le
    • 3
  • Paul R. Pentel
    • 1
  1. 1.Department of MedicineUniversity of MinnesotaMinneapolisUSA
  2. 2.Department of MedicineMinneapolis Medical Research FoundationMinneapolisUSA
  3. 3.Department of BiostatisticsUniversity of MinnesotaMinneapolisUSA

Personalised recommendations